Article info
PDFOriginal research
Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea
- Correspondence to Dr Joo-Young Kim, Proton Therapy Center, National Cancer Center, Goyang-si 10408, the Republic of Korea; jooyoungcasa{at}ncc.re.kr
Citation
Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea
Publication history
- Received January 8, 2020
- Revision received February 20, 2020
- Accepted February 25, 2020
- First published April 9, 2020.
Online issue publication
February 08, 2021
Article Versions
- Previous version (1 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.